There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
The brother of a taxi driver killed alongside the Afghan Taliban leader has asked police to investigate his sibling's death.
The girl's injuries are not thought to be life-threatening.
A dry night ahead, with any showers fading away.